Related Experiment Videos
Manipulating the type 1 vs type 2 balance in type 1 diabetes
Urs Christen1, Matthias G von Herrath
1Department of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA. christen@liai.org
Immunologic Research
|November 9, 2004
Summary
Virus infections trigger type 1 inflammation, potentially causing autoimmune diseases like type 1 diabetes (T1D). This review explores how to restrain this aggressive immune response to prevent T1D autoimmunity.
Area of Science:
- Immunology
- Virology
- Autoimmunity
Background:
- Virus infections induce a potent type 1 inflammatory response essential for pathogen clearance.
- This type 1-skewed immunity can disrupt immune balance, leading to autoimmune conditions.
- Type 1 diabetes (T1D), herpes stromal keratitis, and multiple sclerosis (MS) are examples of virus-associated autoimmune diseases.
Purpose of the Study:
- To review the pathogenesis of type 1 diabetes (T1D) in a virus-induced transgenic mouse model.
- To discuss strategies for modulating aggressive type 1-dominated immune responses.
- To explore methods for abrogating autoimmunity in the context of viral infections.
Main Methods:
- Focus on a virus-induced transgenic mouse model for studying T1D pathogenesis.
- Review existing literature on immune response modulation.
- Analyze mechanisms of autoimmunity induction and potential inhibition.
Main Results:
- Virus-induced type 1 inflammation is a key factor in T1D development.
- Specific immune pathways can be targeted to control excessive inflammation.
- Modulating the immune response shows potential for preventing or reversing T1D.
Conclusions:
- Viral infections can precipitate T1D through aggressive type 1 immune responses.
- Targeting these immune responses offers therapeutic potential for T1D.
- Further research into immune modulation is crucial for treating virus-associated autoimmunity.